| Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE(-/-) Mice by Activating Autophagy and Reducing ER Stress and … N Nasiri-Ansari, C Nikolopoulou, K Papoutsi, I Kyrou, CS Mantzoros, ... International journal of molecular sciences 22 (2), 818, 2021 | 185 | 2021 |
| Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice Ν Nasiri-Ansari, GK Dimitriadis, G Agrogiannis, D Perrea, ID Kostakis, ... Cardiovascular diabetology 17, 1-12, 2018 | 130 | 2018 |
| SGLT-2 inhibitors in NAFLD: expanding their role beyond diabetes and cardioprotection T Androutsakos, N Nasiri-Ansari, AD Bakasis, I Kyrou, E Efstathopoulos, ... International journal of molecular sciences 23 (6), 3107, 2022 | 72 | 2022 |
| Clock genes alterations and endocrine disorders A Angelousi, E Kassi, N Nasiri‐Ansari, MO Weickert, H Randeva, ... European journal of clinical investigation 48 (6), e12927, 2018 | 60 | 2018 |
| Endoplasmic reticulum stress and autophagy in the pathogenesis of non-alcoholic fatty liver disease (NAFLD): current evidence and perspectives CM Flessa, I Kyrou, N Nasiri-Ansari, G Kaltsas, AG Papavassiliou, E Kassi, ... Current obesity reports 10, 134-161, 2021 | 55 | 2021 |
| Clock genes and cancer development in particular in endocrine tissues A Angelousi, E Kassi, N Ansari-Nasiri, H Randeva, G Kaltsas, G Chrousos Endocrine-related cancer 26 (6), R305-R317, 2019 | 55 | 2019 |
| Vascular inflammation and atherosclerosis: the role of estrogen receptors E Kassi, E Spilioti, N Nasiri-Ansari, C Adamopoulos, P Moutsatsou, ... Current Medicinal Chemistry 22 (22), 2651-2665, 2015 | 48 | 2015 |
| Endothelial cell dysfunction and nonalcoholic fatty liver disease (NAFLD): a concise review N Nasiri-Ansari, T Androutsakos, CM Flessa, I Kyrou, G Siasos, ... Cells 11 (16), 2511, 2022 | 45 | 2022 |
| Empagliflozin improves primary haemodynamic parameters and attenuates the development of atherosclerosis in high fat diet fed APOE knockout mice GK Dimitriadis, N Nasiri-Ansari, G Agrogiannis, ID Kostakis, MS Randeva, ... Molecular and cellular endocrinology 494, 110487, 2019 | 45 | 2019 |
| Genetic and diet-induced animal models for non-alcoholic fatty liver disease (NAFLD) research CM Flessa, N Nasiri-Ansari, I Kyrou, BM Leca, M Lianou, ... International Journal of Molecular Sciences 23 (24), 15791, 2022 | 34 | 2022 |
| Endoplasmic reticulum stress in nonalcoholic (metabolic associated) fatty liver disease (NAFLD/MAFLD) CM Flessa, I Kyrou, N Nasiri‐Ansari, G Kaltsas, E Kassi, HS Randeva Journal of Cellular Biochemistry 123 (10), 1585-1606, 2022 | 34 | 2022 |
| Extra-skeletal effects of bisphosphonates A Panagiotakou, M Yavropoulou, N Nasiri-Ansari, P Makras, EK Basdra, ... Metabolism 110, 154264, 2020 | 25 | 2020 |
| The role of epithelial growth factors and insulin growth factors in the adrenal neoplasms A Angelousi, G Kyriakopoulos, N Nasiri-Ansari, M Karageorgou, E Kassi Annals of Translational Medicine 6 (12), 2018 | 23 | 2018 |
| Association between serum and synovial fluid Dickkopf-1 levels with radiographic severity in primary knee osteoarthritis patients T Theologis, N Efstathopoulos, V Nikolaou, I Charikopoulos, I Papapavlos, ... Clinical rheumatology 36, 1865-1872, 2017 | 21 | 2017 |
| Vitamin D interferes with glucocorticoid responsiveness in human peripheral blood mononuclear target cells E Kassi, N Nasiri-Ansari, E Spilioti, V Kalotychou, PE Apostolou, ... Cellular and molecular life sciences 73, 4341-4354, 2016 | 15 | 2016 |
| Fibroblast growth factor 23 (FGF23) and klotho protein in beta-Thalassemia D Stefanopoulos, N Nasiri-Ansari, I Dontas, A Vryonidou, A Galanos, ... Hormone and Metabolic Research 52 (03), 194-201, 2020 | 13 | 2020 |
| Expression of clock-related genes in benign and malignant adrenal tumors A Angelousi, N Nasiri-Ansari, A Karapanagioti, G Kyriakopoulos, C Aggeli, ... Endocrine 68, 650-659, 2020 | 12 | 2020 |
| Management of hematologic malignancies in the era of COVID-19 pandemic: pathogenetic mechanisms, impact of obesity, perspectives, and challenges D Tsilingiris, N Nasiri-Ansari, N Spyrou, F Magkos, M Dalamaga Cancers 14 (10), 2494, 2022 | 10 | 2022 |
| Vitamin D affects glucocorticoid action in target cells E Kassi, N Nasiri-Ansari, AG Papavassiliou Oncotarget 8 (5), 7220, 2017 | 9 | 2017 |
| Estrogen receptor subtypes elicit a distinct gene expression profile of endothelial-derived factors implicated in atherosclerotic plaque vulnerability N Nasiri-Ansari, E Spilioti, I Kyrou, V Kalotychou, A Chatzigeorgiou, ... International Journal of Molecular Sciences 23 (18), 10960, 2022 | 8 | 2022 |
